| Acute Leukemia |
1 |
0.92 |
| Acute Myeloblastic Leukemia |
0 |
0.86 |
| Microbiome |
0 |
0.49 |
| Chemotherapy |
0 |
0.41 |
| DNA Sequencing |
0 |
0.41 |
| Genomic Medicine |
0 |
0.38 |
| Care and Maintenance of Vision |
0 |
0.23 |
| A-Scan Biometry |
0 |
0.21 |
| Scan |
0 |
0.21 |
| Cataract |
0 |
0.19 |
| Social Determinants of Health |
0 |
0.19 |
| Diversity |
0 |
0.14 |
| Remission |
0 |
0.14 |
| Bone Marrow |
0 |
0.1 |
| Bone |
0 |
0.07 |
| Health Care Quality, Access, and Evaluation |
0 |
0.07 |
| Hematological Disorders |
0 |
0.07 |
| Leukemia |
0 |
0.07 |
| Prognosis |
0 |
0.07 |
| Residual Disease |
0 |
0.07 |
| Transplantation |
0 |
0.07 |
| Antibiotics |
0 |
0.06 |